Those findings illustrate that different doses of GJLZ improved liver oxidative stress by enhancing the content of SOD and suppressing the production of MDA; GJLZ could be a prophylactic medicine in lean NAFLD. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.